American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3Ted R. Mikuls, Kenneth G. Saag, Sindhu R. Johnson et al.|Arthritis & Rheumatology|2020Cited by 242
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1Ted R. Mikuls, Kenneth G. Saag, Sindhu R. Johnson et al.|Arthritis & Rheumatology|2020Cited by 186
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2Ted R. Mikuls, Kenneth G. Saag, Sindhu R. Johnson et al.|Arthritis & Rheumatology|2020Cited by 74
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyStanley Cohen, Viatcheslav R. Akmaev, Erin Connolly-Strong et al.|Rheumatology and Therapy|2021Cited by 34
Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid ArthritisStanley Cohen, Viatcheslav R. Akmaev, Jeffrey R. Curtis et al.|Rheumatology and Therapy|2022Cited by 1